Central China New Life Limited

SEHK:9983 Lagerbericht

Marktkapitalisierung: HK$1.5b

Central China New Life Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

Central China New Life wird ein jährliches Gewinn- und Umsatzwachstum von 39.8% bzw. 4.2% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 33.1% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 14.5% betragen.

Wichtige Informationen

39.8%

Wachstumsrate der Gewinne

33.1%

EPS-Wachstumsrate

Real Estate Gewinnwachstum21.1%
Wachstumsrate der Einnahmen4.2%
Zukünftige Eigenkapitalrendite14.5%
Analystenabdeckung

Low

Zuletzt aktualisiert21 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Is Central China New Life (HKG:9983) Using Debt Sensibly?

Oct 09
Is Central China New Life (HKG:9983) Using Debt Sensibly?

After Leaping 29% Central China New Life Limited (HKG:9983) Shares Are Not Flying Under The Radar

Jun 24
After Leaping 29% Central China New Life Limited (HKG:9983) Shares Are Not Flying Under The Radar

Health Check: How Prudently Does Central China New Life (HKG:9983) Use Debt?

Jun 07
Health Check: How Prudently Does Central China New Life (HKG:9983) Use Debt?

Why Investors Shouldn't Be Surprised By Central China New Life Limited's (HKG:9983) 27% Share Price Surge

May 02
Why Investors Shouldn't Be Surprised By Central China New Life Limited's (HKG:9983) 27% Share Price Surge

Central China New Life Limited's (HKG:9983) Shareholders Might Be Looking For Exit

Feb 27
Central China New Life Limited's (HKG:9983) Shareholders Might Be Looking For Exit

Is Central China New Life Limited (HKG:9983) Expensive For A Reason? A Look At Its Intrinsic Value

Nov 22
Is Central China New Life Limited (HKG:9983) Expensive For A Reason? A Look At Its Intrinsic Value

Is Central China New Life (HKG:9983) A Risky Investment?

Sep 25
Is Central China New Life (HKG:9983) A Risky Investment?

Central China New Life Limited (HKG:9983) Analysts Are More Bearish Than They Used To Be

Aug 23
Central China New Life Limited (HKG:9983) Analysts Are More Bearish Than They Used To Be

An Intrinsic Calculation For Central China New Life Limited (HKG:9983) Suggests It's 22% Undervalued

May 09
An Intrinsic Calculation For Central China New Life Limited (HKG:9983) Suggests It's 22% Undervalued

Is It Too Late To Consider Buying Central China New Life Limited (HKG:9983)?

Dec 23
Is It Too Late To Consider Buying Central China New Life Limited (HKG:9983)?

We Think Central China New Life (HKG:9983) Can Manage Its Debt With Ease

Dec 06
We Think Central China New Life (HKG:9983) Can Manage Its Debt With Ease

We Think That There Are Issues Underlying Central China New Life's (HKG:9983) Earnings

Sep 15
We Think That There Are Issues Underlying Central China New Life's (HKG:9983) Earnings

These Analysts Just Made A Noticeable Downgrade To Their Central China New Life Limited (HKG:9983) EPS Forecasts

Aug 26
These Analysts Just Made A Noticeable Downgrade To Their Central China New Life Limited (HKG:9983) EPS Forecasts

Central China New Life's (HKG:9983) Shareholders Will Receive A Bigger Dividend Than Last Year

Apr 04
Central China New Life's (HKG:9983) Shareholders Will Receive A Bigger Dividend Than Last Year

Central China New Life (HKG:9983) Has Announced That It Will Be Increasing Its Dividend To HK$0.34

Mar 21
Central China New Life (HKG:9983) Has Announced That It Will Be Increasing Its Dividend To HK$0.34

The Price Is Right For Central China New Life Limited (HKG:9983)

Jun 01
The Price Is Right For Central China New Life Limited (HKG:9983)

Central China New Life Limited (HKG:9983) Insiders Increased Their Holdings

Feb 23
Central China New Life Limited (HKG:9983) Insiders Increased Their Holdings

What Type Of Shareholders Own The Most Number of Central China New Life Limited (HKG:9983) Shares?

Dec 30
What Type Of Shareholders Own The Most Number of Central China New Life Limited (HKG:9983) Shares?

Gewinn- und Umsatzwachstumsprognosen

SEHK:9983 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (CNY Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/20263,186372N/AN/A1
12/31/20253,036N/AN/AN/A1
12/31/20242,877N/AN/AN/A1
6/30/20242,974-171614623N/A
3/31/20242,909-373262273N/A
12/31/20232,845-574-90-77N/A
9/30/20232,890-301-27-16N/A
6/30/20232,936-273746N/A
3/31/20233,042268164177N/A
12/31/20223,148562291309N/A
9/30/20223,37460668582N/A
6/30/20223,6006491,078-145N/A
3/31/20223,6006341,24317N/A
12/31/20213,5996201,408178N/A
9/30/20213,378561970369N/A
6/30/20213,157503532560N/A
3/31/20212,906465395421N/A
12/31/20202,654427257281N/A
9/30/20202,395368244263N/A
6/30/20202,136310231245N/A
3/31/20201,945274248263N/A
12/31/20191,754239266281N/A
12/31/201869489129133N/A
12/31/201746166N/A84N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: 9983 wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als schnelleres Wachstum als die Sparquote angesehen wird (2.3%).

Ertrag vs. Markt: 9983 wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als überdurchschnittliches Marktwachstum angesehen wird.

Hohe Wachstumserträge: 9983 wird voraussichtlich in den nächsten 3 Jahren rentabel werden.

Einnahmen vs. Markt: 9983Die Einnahmen des Unternehmens (4.2% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Hong Kong (7.8% pro Jahr).

Hohe Wachstumseinnahmen: 9983Die Einnahmen des Unternehmens (4.2% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: 9983Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (14.5%).

Wachstumsunternehmen entdecken

7D

1Y

7D

1Y

7D

1Y